News

1 to 9 of 96288 results

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

30-09-2014

Avacta Life Sciences, a division of Avacta Group is investing £10 million ($16.2 million) in the launch…

AvactaBiotechnologyResearchUK

UCB launches awareness campaign for non-motor symptoms of Parkinson's disease

UCB launches awareness campaign for non-motor symptoms of Parkinson's disease

30-09-2014

Belgian drugmaker UCB has launched an awareness-raising campaign around brain-related illnesses such…

EuropeNeurologicalPharmaceuticalSocial IssuesUCB

NeoGenomics appoints Robert Shovlin as chief operating officer

NeoGenomics appoints Robert Shovlin as chief operating officer

30-09-2014

Cancer-focused genetic testing service provider NeoGenomics has appointed Robert Shovlin as chief operating…

BiotechnologyBoardroomNeoGenomicsOncologyUSA

Intas launches DoceAqualip in India

30-09-2014

Indian drugmaker Intas Pharmaceuticals says it has successfully launched the world’s first DoceAqualip…

DoceAqualipdocetaxelIndiaIntas PharmaceuticalsMarkets & MarketingOncologyPharmaceutical

Innovative and orphan drugs to become more accessible in Russia

30-09-2014

The Russian Parliament (State Duma) plans to ease access to innovative and orphan drugs to the Russian…

PharmaceuticalRegulationResearchRussia

Biosimilars set to revolutionize global drug development industry

30-09-2014

Intellectual Property and Science business of Thomson Reuters today announced the release of Biosimilars:…

BiosimilarsBiotechnologyGlobalMarkets & MarketingResearch

Sanofi may build new plant in Russia

30-09-2014

French pharma major Sanof plans to build a new plant in Russia, which is expected to be located in the…

PharmaceuticalProductionRussiaSanofi

1 to 9 of 96288 results

Back to top